286 related articles for article (PubMed ID: 17011665)
1. Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus.
Sauerbrei A; Schacke M; Glück B; Egerer R; Wutzler P
J Hosp Infect; 2006 Dec; 64(4):358-65. PubMed ID: 17011665
[TBL] [Abstract][Full Text] [Related]
2. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
3. Does limited virucidal activity of biocides include duck hepatitis B virucidal action?
Sauerbrei A; Schacke M; Glück B; Bust U; Rabenau HF; Wutzler P
BMC Infect Dis; 2012 Oct; 12():276. PubMed ID: 23110658
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human adenoviruses to different groups of chemical biocides.
Sauerbrei A; Sehr K; Brandstädt A; Heim A; Reimer K; Wutzler P
J Hosp Infect; 2004 May; 57(1):59-66. PubMed ID: 15142717
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of human adenovirus genome by different groups of disinfectants.
Sauerbrei A; Sehr K; Eichhorn U; Reimer K; Wutzler P
J Hosp Infect; 2004 May; 57(1):67-72. PubMed ID: 15142718
[TBL] [Abstract][Full Text] [Related]
6. Hexon denaturation of human adenoviruses by different groups of biocides.
Sauerbrei A; Eichhorn U; Scheibenzuber M; Wutzler P
J Hosp Infect; 2007 Mar; 65(3):264-70. PubMed ID: 17241695
[TBL] [Abstract][Full Text] [Related]
7. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
9. Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?
Sauerbrei A
World J Gastroenterol; 2014 Jan; 20(2):436-44. PubMed ID: 24574712
[TBL] [Abstract][Full Text] [Related]
10. Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks.
Cullen JM; Marion PL; Sherman GJ; Hong X; Newbold JE
Cancer Res; 1990 Jul; 50(13):4072-80. PubMed ID: 1972346
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
13. Virucidal activity of ortho-phthalaldehyde solutions against hepatitis B and C viruses.
Roberts CG; Chan-Myers HB; Favero MS
Am J Infect Control; 2008 Apr; 36(3):223-6. PubMed ID: 18371520
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
Jilbert AR; Miller DS; Scougall CA; Turnbull H; Burrell CJ
Virology; 1996 Dec; 226(2):338-45. PubMed ID: 8955053
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
[TBL] [Abstract][Full Text] [Related]
16. In vitro cultivation and cryopreservation of duck embryonic hepatocytes.
Schacke M; Glück B; Wutzler P; Sauerbrei A
J Virol Methods; 2009 Apr; 157(1):25-31. PubMed ID: 19124040
[TBL] [Abstract][Full Text] [Related]
17. Delipidation of a hepadnavirus: Viral inactivation and vaccine development.
Cham BE; Vickery K; Tohidi-Esfahani R; Cossart Y
J Virol Methods; 2006 Oct; 137(1):160-3. PubMed ID: 16808980
[TBL] [Abstract][Full Text] [Related]
18. Dot blot hybridization assay for the detection of duck hepatitis B virus DNA among healthy Indian country ducks.
Valliammai T; Sridhar G; Thyagarajan SP; Ramakrishnan J; Gopal KV; Harrison TJ; Jayaraman K
Indian J Pathol Microbiol; 1994 Jan; 37(1):53-8. PubMed ID: 8088900
[TBL] [Abstract][Full Text] [Related]
19. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
20. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure.
Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L
Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
